AUA 2014 - Bladder Cancer

Viewing 1-14 of 14 articles

#AUA14 - State-of-the-Art Lecture: Clinical implications of The Cancer Genome Atlas Project on muscle-invasive bladder cancer - Session Highlights

#AUA14 - Performance of primary radical cystectomy and risk of pathologic upstaging in patients with Stage I high grade urothelial carcinoma of the bladder: A National Cancer Database analysis - Session Highlights

#AUA14 - State-of-the-Art Lecture: Development of bladder cancer biomarkers - Session Highlights

#AUA14 - Poster: Performance of early radical cystectomy and risk of pathologic upstaging in patients with stage I high grade urothelial carcinoma of the bladder: A National Cancer Database analysis

#AUA14 - Do circulating tumor cells help in decision-making regarding adjuvant chemotherapy in patients with urothelial carcinoma of the bladder treated with radical cystectomy? - Session Highlights

#AUA14 - Differential gene expression in responsive versus recurrent non-muscle invasive high-grade urothelial carcinomas after induction BCG - Session Highlights

#AUA14 - The oxidative stress response of urothelial carcinoma cells to BCG exposure - Session Highlights

#AUA14 - Predicting response to bacillus Calmette-Guerin (BCG) - Session Highlights

#AUA14 - Neutrophil-to-lymphocyte ratio (NLR): Prognostic indicator for overall survival (OS) in patients undergoing radical cystectomy (RC) - Session Highlights

#AUA14 - Is extended pharmacological venous thromboembolism prophylaxis uniformly safe following radical cystectomy? - Session Highlights

#AUA14 - Poster: How safe is extended pharmacological venous thromboembolism prophylaxis (EPVTEP) following radical cystectomy?

#AUA14 - Treatment patterns in patients with recurrent high-risk bladder cancer - Session Highlights

#AUA14 - Evaluation of the ACS NSQIP Surgical Risk Calculator in patients undergoing radical cystectomy - Session Highlights

#AUA14 - Poster: Evaluation of the ACS NSQIP Surgical Risk Calculator in patients undergoing radical cystectomy